Clinical Research Progress on the Gilles de la Tourette Syndrome

Dear Colleagues,

We invite papers for submission to a Special Issue of the Journal of Clinical Medicine on “Clinical Research Progress on the Gilles de la Tourette Syndrome”. Multidisciplinary clinical and fundamental investigations have revolutionized the comprehension of persistent tic disorders and Gilles de la Tourette Syndrome. Studies in the field of psychology, psychiatry, neurology, neurosurgery, and many more are increasingly providing new insights into longstanding questions about tic disorders, such as (1) the development of new cognitive–behavioral therapy; (2) psychopharmacological treatment; (3) new cutting-edge treatments such as neuromodulation, deep-brain stimulation, and neurofeedback, among others.

In this Special Issue, we expect to feature the latest cutting-edge research into the evaluation and treatment of tic disorders. We also seek to emphasize conceptual frameworks that synthesize the current understanding of this field of research and suggest new outstanding questions and directions for further investigations. This Special Issue should be of interest to a broad audience interested in the treatment of tic disorders. We welcome manuscripts that examine, among others, the following research areas:

• Psychological, psychiatric, and neurological evaluation of tic disorders;
• Understanding tic disorders via large-scale network interactions;
• Theoretical issues in the neurobiology of tic disorders;
• Functional connectivity and tic symptoms;
• Clinical evolution following cognitive–behavioral therapy;
• The neurobiological and cognitive effect of pharmacotherapy;
• Immunobiology and neuroimmunology;
• Neurofeedback and biofeedback;
• Gene–environment interactions and next-generation sequencing;
• Brain plasticity and social environment;
• Quality of life and clinical outcome;
• New psychometric tools for the evaluation of tics and associated symptoms.

This Special Issue will bring together original research, reviews, and meta-analyses. Priority will be given to empirical articles reporting evaluation and treatment data. Reviews may be considered if they offer substantial new insights into important questions and issues.

Please submit a tentative title and abstract (250 words maximum) by 1 March 2023 to Marc Lavoie (marc.lavoie@umontreal.ca) or Julie Leclerc (leclerc.julie@uqam.ca). All submitted abstracts will be reviewed by June 2023, and invitations to submit complete manuscripts will be issued based on appropriateness for the Special Issue and a balance of themes. Please feel free to share this announcement with your colleagues. The full manuscript should be submitted by September 2023.

Prof. Dr. Marc Lavoie
Prof. Dr. Julie B. Leclerc
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.